Kaposi's sarcoma echocardiograph and ultrasound: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Kaposi's sarcoma}} | {{Kaposi's sarcoma}} | ||
{{CMG}} {{shyam}}; {{AE}} {{ADS}} | |||
{{CMG}} {{shyam}}; {{AE}} | |||
==Overview== | ==Overview== | ||
| Line 8: | Line 7: | ||
==Echocardiography/Ultrasound== | ==Echocardiography/Ultrasound== | ||
There are no specific echocardiography/ultrasound findings associated with Kaposi's sarcoma. However, echocardiograph is necessary if liposomal doxorubicin is used as therapy, since this medication causes cardiomyopathy. Routine echocardiographs may need to be done throughout therapy, typically once every 3 months.<ref name="pmid25939787">{{cite journal| author=Sadurska E| title=Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. | journal=Pediatr Cardiol | year= 2015 | volume= 36 | issue= 6 | pages= 1112-9 | pmid=25939787 | doi=10.1007/s00246-015-1176-7 | pmc=4495714 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25939787 }} </ref> | *There are no specific echocardiography/ultrasound findings associated with Kaposi's sarcoma. | ||
* However, echocardiograph is necessary if liposomal doxorubicin is used as therapy, since this medication causes cardiomyopathy. Routine echocardiographs may need to be done throughout therapy, typically once every 3 months.<ref name="pmid25939787">{{cite journal| author=Sadurska E| title=Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. | journal=Pediatr Cardiol | year= 2015 | volume= 36 | issue= 6 | pages= 1112-9 | pmid=25939787 | doi=10.1007/s00246-015-1176-7 | pmc=4495714 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25939787 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:HIV/AIDS]] | |||
[[Category:Types of cancer]] | |||
[[Category:Dermatology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Gastroenterology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Vascular medicine]] | |||
[[Category:Surgery]] | |||
Latest revision as of 14:29, 27 March 2019
|
Kaposi's sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Kaposi's sarcoma echocardiograph and ultrasound On the Web |
|
American Roentgen Ray Society Images of Kaposi's sarcoma echocardiograph and ultrasound |
|
Risk calculators and risk factors for Kaposi's sarcoma echocardiograph and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3]
Overview
There are no specific echocardiography/ultrasound findings associated with Kaposi's sarcoma.
Echocardiography/Ultrasound
- There are no specific echocardiography/ultrasound findings associated with Kaposi's sarcoma.
- However, echocardiograph is necessary if liposomal doxorubicin is used as therapy, since this medication causes cardiomyopathy. Routine echocardiographs may need to be done throughout therapy, typically once every 3 months.[1]
References
- ↑ Sadurska E (2015). "Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors". Pediatr Cardiol. 36 (6): 1112–9. doi:10.1007/s00246-015-1176-7. PMC 4495714. PMID 25939787.